海外の治験の状況「前立腺癌」での検索結果
107件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- A Randomized, Double-Blind, Parallel-Group Trial Comparing Bicalutamide (Casodex) 150mg Once Daily With Placebo in Patients With Non-metastatic Prostate Cancer
- Non-Metastatic Prostate Cancer;C61 - Malignant neoplasm of prostate
- Australia, Austria, Belgium, Czech Republic, Germany, Hungary, Ireland, Israel, Italy, Mexico, Netherlands, Poland, Portugal, South Africa, Spain, United Kingdom
- 2015-11-12
Not Recruiting
- A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and Safety of Dutasteride 0.5 mg Administered Orally Once Daily for Four Years to Reduce the Risk of Biopsy-Detectable Prostate Cancer
- Neoplasms, Prostate;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belarus, Belgium, Brazil, Bulgaria, Canada, Chile, Croatia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Latvia, Lithuania, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Tunisia, Turkey, Ukraine, United Kingdom, United States
- 2015-11-12
Not Recruiting
- Efficacy and Safety of a New Leuprolide Acetate 3.75 mg Depot Formulation, GP-Pharm S.A., When Given as Palliative Treatment to Prostate Cancer Patients
- Prostate Cancer;C61 - Malignant neoplasm of prostate
- Austria, Czech Republic, Germany, Hungary, Italy, Slovakia, Spain, United Kingdom, United States
- 2015-11-11
Not recruiting
- Analysis of Androgene Receptors Axis and DNA Damage Repair Genes in Patients With Prostate Cancer
- Prostatic Neoplasms
- Austria
- 2018-09-17
Not recruiting
- Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma
- Prostatic Neoplasms;Prostatic Neoplasms;Prostatic Neoplasms
- Austria, Czech Republic, Czechia, Germany, Lithuania, Poland, Slovakia, Taiwan, United States
- 2014-09-01
Not recruiting
- "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk
- Neoplasms, Prostate;Neoplasms, Prostate;Neoplasms, Prostate;Neoplasms, Prostate
- Argentina, Australia, Austria, Belarus, Belgium, Brazil, Bulgaria, Canada, Chile, Croatia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Latvia, Lithuania, Mexico, Netherlands, New Zealand, Norway, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Tunisia, Turkey, Ukraine, United Kingdom, United States
- 2003-03-11
Not recruiting
- Radiotherapy - Adjuvant Versus Early Salvage
- Prostate Cancer;Prostate Cancer;Prostate Cancer;Prostate Cancer
- Australia, New Zealand
- 2009-03-10
Not Recruiting
- Measurement of variation in imaging report findings for 68Ga-PSMA-11 PET/CT in patients with prostate cancer: an international study with participation of multiple centers
- Prostate cancer br>Cancer
- Australia, Austria, Denmark, France, Germany, Japan, United States of America
- 2016-10-27
Not Recruiting
- AFFIRM: A Multinational Phase 3, Randomized, Double-Blind, Placebo-COntrolled Efficacy and Safety Study of Oral MDV3100 in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
- Castration-Resistant Prostate Cancer;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belgium, Canada, Chile, France, Germany, Italy, Netherlands, Poland, South Africa, Spain, United Kingdom, United States
- 2014-04-14
Not recruiting
- Phase III Study of DCVAC Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer
- Metastatic Castrate Resistant Prostate Cancer
- Austria, Belarus, Belgium, Bulgaria, Croatia, Czech Republic, Czechia, Denmark, France, Germany, Hungary, Italy, Latvia, Lithuania, Netherlands, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Turkey, United Kingdom, United States
- 2014-04-09